Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Stockholders' (Deficit) Equity

v3.19.1
Consolidated Statement of Changes in Stockholders' (Deficit) Equity - USD ($)
Total
Prostagene Llc [Member]
Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Prostagene Llc [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Prostagene Llc [Member]
Accumulated Deficit [Member]
Beginning balance (Fiscal Year To Date) at May. 31, 2018 $ (13,157,971)                
Beginning balance at May. 31, 2018 (13,157,971)   $ 92 $ 216,881   $ (159) $ 159,764,611   $ (173,139,396)
Beginning balance, shares at May. 31, 2018     92,100 216,881,790   159,011      
Proceeds from registered direct offering | Fiscal Year To Date 985,000                
Proceeds from registered direct offering 985,000     $ 1,970     983,030    
Proceeds from registered direct offering, shares       1,970,000          
Offering costs related to registered direct offering, value | Fiscal Year To Date (75,151)                
Offering costs related to registered direct offering, value (75,151)   $ 0 $ 0   $ 0 (75,151)    
Offering costs related to registered direct offering, shares     0 0   0      
Proceeds from private equity offering, value | Fiscal Year To Date 7,514,300                
Proceeds from private equity offering, value 7,514,300     $ 15,029     7,499,271    
Proceeds from private equity offering, shares       15,028,600          
Offering costs related to private equity offering, value | Fiscal Year To Date (882,716)                
Offering costs related to private equity offering, value (882,716)           (882,716)    
Legal fees in connection with equity offerings | Fiscal Year To Date (50,544)                
Legal fees in connection with equity offerings (50,544)           (50,544)    
Stock-based compensation | Fiscal Year To Date 283,346                
Stock-based compensation 283,346           283,346    
Net loss | Fiscal Year To Date (14,413,569)                
Net loss (14,413,569)               (14,413,569)
Ending balance (Fiscal Year To Date) at Aug. 31, 2018 (19,797,305)                
Ending balance at Aug. 31, 2018 (19,797,305)   $ 92 $ 233,880   $ (159) 167,521,847   (187,552,965)
Ending balance, shares at Aug. 31, 2018     92,100 233,880,390   159,011      
Beginning balance (Fiscal Year To Date) at May. 31, 2018 (13,157,971)                
Beginning balance at May. 31, 2018 (13,157,971)   $ 92 $ 216,881   $ (159) 159,764,611   (173,139,396)
Beginning balance, shares at May. 31, 2018     92,100 216,881,790   159,011      
Acquisition   $ 11,558,000              
Net loss (41,292,761)                
Ending balance (Fiscal Year To Date) at Feb. 28, 2019 (6,249,039)                
Ending balance at Feb. 28, 2019 (6,249,039)   $ 92 $ 304,680   $ (159) 207,878,504   (214,432,156)
Ending balance, shares at Feb. 28, 2019     92,100 304,679,081   159,011      
Beginning balance (Fiscal Year To Date) at Aug. 31, 2018 (19,797,305)                
Beginning balance at Aug. 31, 2018 (19,797,305)   $ 92 $ 233,880   $ (159) 167,521,847   (187,552,965)
Beginning balance, shares at Aug. 31, 2018     92,100 233,880,390   159,011      
Acquisition | Fiscal Year To Date   11,558,000              
Acquisition   11,558,000     $ 18,658     $ 11,539,342  
Acquisition, share         18,658,000        
Issuance of stock payment shares | Fiscal Year To Date 8,342                
Issuance of stock payment shares 8,342     $ 8,342          
Issuance of stock payment shares, shares       8,342,000          
Issuance of stock for note payable redemption            
Issuance of stock for note payable redemption ,shares     0 0   0      
Proceeds from registered direct offering | Fiscal Year To Date 985,000                
Offering costs related to registered direct offering, value | Fiscal Year To Date (75,151)                
Offering costs related to registered direct offering, value     $ 0 $ 0   $ 0      
Offering costs related to registered direct offering, shares     0 0   0      
Proceeds from private equity offering, value | Fiscal Year To Date 22,478,584                
Proceeds from private equity offering, value 14,964,284     $ 29,930     14,934,355    
Proceeds from private equity offering, shares       29,928,570          
Offering costs related to private equity offering, value | Fiscal Year To Date (2,576,070)                
Offering costs related to private equity offering, value (1,693,354)           (1,693,354)    
Offering costs related to debt offering     $ 0 $ 0   $ 0      
Legal fees in connection with equity offerings | Fiscal Year To Date (76,196)                
Legal fees in connection with equity offerings (25,652)           (25,652)    
Stock-based compensation | Fiscal Year To Date 1,510,486                
Stock-based compensation 1,227,140           1,227,140    
Net loss | Fiscal Year To Date (28,718,950)                
Net loss (14,305,381)               (14,305,380)
Ending balance (Fiscal Year To Date) at Nov. 30, 2018 (8,063,926)                
Ending balance at Nov. 30, 2018 (8,063,926)   $ 92 $ 290,810   $ (159) 193,503,678   (201,858,345)
Ending balance, shares at Nov. 30, 2018     92,100 290,808,960   159,011      
Acquisition | Fiscal Year To Date   11,558,000              
Acquisition   $ 11,558,000              
Issuance of stock payment shares | Fiscal Year To Date 0                
Issuance of stock payment shares 0     $ 0     0    
Issuance of stock payment shares, shares       0          
Issuance of stock for note payable redemption | Fiscal Year To Date 455,000                
Issuance of stock for note payable redemption 455,000     $ 1,124     453,876    
Issuance of stock for note payable redemption ,shares       1,123,641          
Proceeds from registered direct offering | Fiscal Year To Date 6,349,241                
Proceeds from registered direct offering 5,364,241     $ 10,728     5,353,511    
Proceeds from registered direct offering, shares       10,728,480          
Offering costs related to registered direct offering, value | Fiscal Year To Date (621,121)                
Offering costs related to registered direct offering, value (545,970)   $ 0 $ 0   $ 0 (545,970)    
Offering costs related to registered direct offering, shares     0 0   0      
Proceeds from private equity offering, value | Fiscal Year To Date 23,487,584                
Proceeds from private equity offering, value 1,009,000     $ 2,018     1,006,982    
Proceeds from private equity offering, shares       2,018,000          
Offering costs related to private equity offering, value | Fiscal Year To Date (2,697,149)                
Offering costs related to private equity offering, value (121,079)           (121,079)    
Offering costs related to debt offering | Fiscal Year To Date 260,636                
Offering costs related to debt offering 260,636           260,636    
Debt discount and issuance costs related to offering | Fiscal Year To Date 3,059,159                
Debt discount and issuance costs related to offering 3,059,159           3,059,159    
Beneficial conversion feature on note payable and relative fair value associated with warrants | Fiscal Year To Date 3,534,992                
Beneficial conversion feature on note payable and relative fair value associated with warrants 3,534,992           3,534,992    
Legal fees in connection with equity offerings | Fiscal Year To Date (76,196)                
Stock-based compensation | Fiscal Year To Date 2,891,547                
Stock-based compensation 1,372,719           1,372,719    
Net loss | Fiscal Year To Date (41,292,761)                
Net loss (12,573,811)               (12,573,811)
Ending balance (Fiscal Year To Date) at Feb. 28, 2019 (6,249,039)                
Ending balance at Feb. 28, 2019 $ (6,249,039)   $ 92 $ 304,680   $ (159) $ 207,878,504   $ (214,432,156)
Ending balance, shares at Feb. 28, 2019     92,100 304,679,081   159,011